Tianmu Biotechnology has completed a financing of 100 million yuan, accelerating the industrialization of life science instruments

Recently, Tianmu Biotechnology completed a Series B financing of nearly RMB 100 million. This round of financing is fromQingkong Jinxin and Tianchuang Capital lead the investment, with Shanshui Green Energy following suitThree years ago, the well-known domestic investment institution Qianhai Ark invested in Tianmu Biotechnology, which effectively promoted the company's development; The financing company will further accelerate the research and market promotion of scientific instruments in the fields of biomedicine and biomanufacturing.

Tianmu Biotechnology is a well-known life science instrument company in China that focuses on original technology research and instrument innovation. It is a "national high-tech enterprise" and a provincial-level "specialized, refined, and innovative enterprise". The company was incubated at the Wuxi Institute of Applied Technology, Tsinghua University. The initial entrepreneurial team came from the Tsinghua University Biobreeding Technology and Equipment Team; The company maintains long-term and deep strategic cooperation with research teams from multiple universities such as Tsinghua University, Chinese Academy of Sciences, and Jiangnan University.

The company has established several core technology systems, including plasma biotechnology, microfluidics technology, automated detection technology, and biosensor technology. It has also developed over 20 original products, including plasma mutagenesis breeding equipment, high-throughput single-cell droplet sorting equipment, droplet continuous propagation and evolution equipment, and online detection equipment for biological culture processes. After years of research and development, the company's products have achieved full coverage across multiple levels of cell culture, detection, and sorting systems, from skin, nano, and micro upgrades to milliliters and upgrades. The company has also creatively connected different systems, maximizing the advantages of each level of system; The combination of related instruments and equipment is flexible and widely applicable, and can be widely used in many fields such as synthetic biology, biomanufacturing, drug development, biological breeding, and biological detection, achieving a significant improvement in research and development efficiency.

The company's products have won numerous awards such as the "China Patent Excellence Award", "China Light Industry Federation Science and Technology Invention First Prize", and "Geneva International Invention Exhibition Gold Award" for their outstanding technological innovation; The product has also passed CE certification and UL certification, and is exported to multiple countries such as Japan, the United States, Denmark, Singapore, France, and Russia.

The company always takes customer needs as the guide, adheres to equipment innovation, method development, and technical services simultaneously, and strives to provide customers with complete and practical solutions of "hardware equipment+methods". The team has developed dozens of biosensors for microfluidic systems and customized dozens of high-throughput cell culture and sorting methods for different user needs.

The development of the company cannot be separated from the long-term tolerance, trust, and support of our customers! Tianmu products have served over 500 customers at home and abroad, and customers have published more than 2000 articles using the products. The company will adhere to the guidance of industry pain points and actual needs, with the goal of developing products that customers can afford and use well, continuously optimizing products, enhancing team service capabilities, and contributing greater strength to the development of the biotechnology industry.

Tianmu Biotechnology sincerely thanks the investment institution for their support and trust! Scientific instruments are compared to pearls in the manufacturing industry. The company will continue to uphold the corporate values of "down-to-earth, innovative, customer-oriented, and striving for excellence" and work together with peer enterprises to bring more scientific instruments created in China to the world.

Introduction of investment institutions in this round:

Jinxin Capital (Beijing Qingkong Jinxin Investment Management Co., Ltd.) was founded in 2013, relying on the advantages of Tsinghua's production, education, and research resources, adhering to the concept of "technology oriented, finance oriented", and deeply cultivating strategic emerging industries and financial capital markets. It has become an important force in promoting the coordinated development of industry finance integration in Tsinghua's industry, and is a professional institution specializing in industrial investment and asset management for member enterprises of Tsinghua Holdings' Qingkong Asset Management Group. As of now, the total size of Jinxin Capital Management Fund exceeds 25 billion yuan.

Tianchuang Capital (Tianjin Venture Capital Management Co., Ltd.) was established in 2003. Since its commercial operation, it has relied on its profound industry accumulation and government background, and is based in Tianjin. I have been deeply involved in the field of venture capital for 20 years, managing a total fund size of 10 billion yuan and investing in over 130 technology-based enterprises. The proportion of listed companies in my portfolio is nearly 20%.

Shanshui Green Energy (Shanshui Green Energy Venture Capital Partnership Enterprise (Limited Partnership)) is a fund under Xingyuan Capital. Wuxi Xingyuan Private Equity Fund Management Co., Ltd. is a state-owned and mixed ownership venture capital platform in Wuxi High tech Zone, and is the vice president unit of Wuxi High tech Zone Venture Capital Promotion Association. Since its establishment, Xingyuan Capital has been deeply involved in the field of equity investment, conducting empowering investments in multiple strategic emerging industries such as manufacturing, biomedicine, and new energy in the Yangtze River Delta region, covering the entire lifecycle of technology enterprises. It has grown into a venture capital brand with a certain asset management scale and industry influence in the region.